Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-11.64M.
ENTERPRISE VALUE (EV)
$-11.64M
IN8bio, Inc.
Market Cap
$13.89M
Enterprise Value (EV)
$-11.64M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| IN8bio, Inc. (INAB) | $13.89M | $-11.64M |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.88M | $4.05M |
| Vyome Holdings, Inc. (HIND)vs › | $13.97M | $6.10M |
| Optimi Health Corp. (OPTH)vs › | $13.48M | $7.90M |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.44M | $11.31M |
| Obsidian Therapeutics Inc. (OBX)vs › | $14.56M | N/A |
| Passage Bio, Inc. (PASG)vs › | $12.98M | N/A |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.86M | N/A |
| Pasithea Therapeutics Corp. (KTTA)vs › | $14.95M | N/A |
| Lantern Pharma Inc. (LTRN)vs › | $12.76M | $6.14M |
Market Cap
$13.89M
Total Debt
$1.56M
Cash
$27.09M
Enterprise Value
$-11.64M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
